Lonza Group AG: NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms
(2) NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage forms Centers of excellence employing a total of 390 staff offer expertise in Lipid Oral Dosage Forms including softgels and liquid-filled hard capsules for the pharma and nutrition markets Sustainable growth and people development a priority for both companies A French version of this release is also available Quote from Gordon Ba...
Source: finanznachrichten.de